WHO and EMA Warnings About Semaglutide and NAION In June 2025, the World Health Organization alerted healthcare professionals and regulatory authorities to the risk of non-arteritic anterior ischemic optic neuropathy (NAION) associated with semaglutide medications, including Ozempic, Rybelsus, and Wegovy
Review your history, medication eligibility, and create a personalized plan
Hopefully to order more from you
How to Use Tirzepatide Effectively Administered as a once-weekly tirzepatide injection, this treatment requires consistent timing and proper technique, guided by your provider
Some plans explicitly exclude GLP-1 medications, weight loss drugs, or specific brand names
Kidney or Liver Disease Dose adjustments may not always be required, but careful monitoring is recommended